Your browser doesn't support javascript.
loading
Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.
Kim, S T; Kim, S Y; Klempner, S J; Yoon, J; Kim, N; Ahn, S; Bang, H; Kim, K-M; Park, W; Park, S H; Park, J O; Park, Y S; Lim, H Y; Lee, S H; Park, K; Kang, W K; Lee, J.
Afiliação
  • Kim ST; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim SY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Klempner SJ; The Angeles Clinic and Research Institute, Los Angeles, USA.
  • Yoon J; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Kim N; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Ahn S; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Bang H; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Kim KM; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park W; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park SH; The Innovative Cancer Medicine Institute, Samsung Medical Center, Seoul, Korea.
  • Park JO; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park YS; The Innovative Cancer Medicine Institute, Samsung Medical Center, Seoul, Korea.
  • Lim HY; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kang WK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ann Oncol ; 28(3): 547-554, 2017 03 01.
Article em En | MEDLINE | ID: mdl-28028034
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Morfolinas / Proteína Companheira de mTOR Insensível à Rapamicina / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Morfolinas / Proteína Companheira de mTOR Insensível à Rapamicina / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article